Beyond Weight Loss: How GLP-1 Agonists Influence Gut Bioenergetics and the Host Capacity Model — Discussing This With Your Clinical Team

If you are managing persistent symptoms across SIBO, MCAS, long COVID, or chronic fatigue, and the standard approaches have not produced durable change, a structured mechanistic interpretation can support the conversation you are already having with your licensed clinicians. BiomeLogic provides educational systems-biology consulting and written mechanistic summaries to help you and your medical team think clearly about candidate upstream mechanisms, including the bioenergetic and microbial dimensions discussed above. This is not medical diagnosis or treatment.